Confluence Genetics
2025
- Kim Hurst, CEO
St Louis, MO
- Increased uptake of practices, products, and technologies that enhance agricultural productivity Jump to footnote 1
The company leverages a combination of its world-leading proprietary germplasm, its AI-driven seed breeding CropOS® technology platform, and the rapid prototyping capabilities enabled by its Crop Accelerator. Confluence Genetics collaborates with strategic partners to create value throughout the agribusiness supply chain to meet the demand for better feed, food, and fuel.
Insights
Footnotes
S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.